Examining the latent structure of negative symptoms: Is there a distinct subtype of negative symptom schizophrenia?

被引:81
|
作者
Blanchard, JJ [1 ]
Horan, WP
Collins, LM
机构
[1] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
schizophrenia; negative symptoms; deficit syndrome; taxometrics;
D O I
10.1016/j.schres.2005.03.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Negative symptoms have emerged as a replicable factor of symptomatology within schizophrenia. Although rating scales provide assessments along dimensions of severity, categorization into a negative symptom subtype is typically conducted. A categorical view of negative symptoms is best reflected in the proposal that enduring, primary negative symptoms, or deficit symptoms, reflect a distinct subtype of schizophrenia [Carpenter, W.T., Heinrichs, D.W., Wagman, A.M.I., 1988. Deficit and nondeficit forms of schizophrenia: The concept. Am. J. Psychiatry 145, 578-583.]. Despite an accumulation of findings that support a categorical conceptualization, the data are also consistent with a dimensional-only model where negative symptom subtypologies simply reflect an extreme on a continuum of severity. Using taxometric statistical methods [Waller, N.G., Meehl, P.E., 1998. Multivariate Taxometric Procedures: Distinguishing Types From Continua. Sage, Newbury Park, CA.], the present study examined whether a taxonic, or latent class, model best describes negative symptoms in a sample of 238 schizophrenia patients. In order to obtain more stable estimates of symptoms, ratings on the Scale for the Assessment of Negative Symptoms [Andreasen, N.C., 1982. Negative symptoms in schizophrenia: Definition and reliability. Arch. Gen. Psychiatry 39, 784-788.] were averaged across two assessments over a 6-month period. Two taxomettic methods, maximum covariance analysis (MAXCOV) and mean above minus below a cut (MAMBAC) identified a latent class or taxon with a base rate of approximately 28-36%. Members of the negative symptom taxon differed from the nontaxon class in that taxon members were more likely to be male and demonstrated poorer social functioning. Taxon and nontaxon schizophrenia patients did not differ in psychotic or affective symptoms. The findings converge to provide support for a categorical view of negative symptoms. Further research is required to replicate the present taxonic findings and to examine characteristics (including possible etiological factors) associated with this negative symptom taxon. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 165
页数:15
相关论文
共 50 条
  • [21] Distress attributed to negative symptoms in schizophrenia
    Selten, JP
    Wiersma, D
    van den Bosch, RJ
    SCHIZOPHRENIA BULLETIN, 2000, 26 (03) : 737 - 744
  • [22] Conceptualization and treatment of negative symptoms in schizophrenia
    Sarkar, Sonali
    Hillner, Kiley
    Velligan, Dawn I.
    WORLD JOURNAL OF PSYCHIATRY, 2015, 5 (04): : 352 - 361
  • [23] Negative symptoms of schizophrenia: historical aspects
    Pringuey, D.
    Paquin, N.
    Cherikh, F.
    Giordana, B.
    Belzeaux, R.
    Cermolacce, M.
    Adida, M.
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 : 6S3 - 6S8
  • [24] Stability of positive and negative symptoms in schizophrenia
    Ribeyre, JM
    Dollfus, S
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1996, 22 : 29 - 31
  • [25] Treating Negative Symptoms in Schizophrenia: an Update
    Remington G.
    Foussias G.
    Fervaha G.
    Agid O.
    Takeuchi H.
    Lee J.
    Hahn M.
    Current Treatment Options in Psychiatry, 2016, 3 (2) : 133 - 150
  • [26] Assessment of Pharmacotherapy for Negative Symptoms of Schizophrenia
    Elizabeth Hanson
    Kristin Healey
    Daniel Wolf
    Christian Kohler
    Current Psychiatry Reports, 2010, 12 : 563 - 571
  • [27] The negative symptoms of schizophrenia: A cognitive perspective
    Rector, NA
    Beck, AT
    Stolar, N
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (05): : 247 - 257
  • [28] Sulforaphane for the Treatment of Negative Symptoms in Schizophrenia
    Smith, Robert
    Huang, Jing
    Chen, AnMei
    Jin, Hua
    Davis, John M.
    Wu, Renrong
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 348 - 349
  • [29] Drug treatment of the negative symptoms of schizophrenia
    King, DJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (01) : 33 - 42
  • [30] POSITIVE AND NEGATIVE SYMPTOMS IN FAMILIES WITH SCHIZOPHRENIA
    BASSETT, AS
    COLLINS, EJ
    NUTTALL, SE
    HONER, WG
    SCHIZOPHRENIA RESEARCH, 1993, 11 (01) : 9 - 19